| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adrenoceptor alpha 2A | 0.578 | 0.615 | 8.2E-04 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2001 | 2011 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.380 | None | 1.000 | 4 | 0 | 2001 | 2020 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2001 | 2018 | ||||||||
|
dual specificity phosphatase 4 | 0.603 | 0.654 | 0.88 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2001 | 2005 | ||||||||
|
mitogen-activated protein kinase 8 | 0.397 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2017 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2001 | 2004 | ||||||||
|
aralkylamine N-acetyltransferase | 0.670 | 0.692 | 3.0E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2020 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2002 | 2011 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
disease | 0.360 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2002 | 2013 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
disease | 0.320 | None | 0.800 | 5 | 0 | 2003 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2018 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2003 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.590 | None | 1.000 | 5 | 0 | 2003 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.620 | None | 1.000 | 4 | 0 | 2003 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
disease | 0.320 | None | 1.000 | 4 | 0 | 2003 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.350 | None | 0.500 | 4 | 0 | 2003 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2008 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2019 |